/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
BlueLinx is a leading wholesale distributor of residential and commercial building products in the United States. Two-step distributors purchase products from manufacturers and distribute those products to dealers and other suppliers in local markets, who then sell those products to end users.
$77.28
+$1.48 (+1.95%)
Live · 11:05 PM
Operating margin is thin at 2.39%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue growth slowed to 0.0%, essentially flat. This is a business that needs a catalyst.
Free cash flow declined 27% versus the prior year, cash generation momentum has weakened. Net debt of $288M represents 8.8x FCF, leverage limits flexibility.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$3.01B
Net Income (TTM)
-$2M
▼ -99.6% YoY
Op. Margin
2.42%
▼ -0.6pp YoY
ROIC
5.58%
▼ -1.2pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$58M
▼ -27.1% YoY
Op. Cash Flow (TTM)
$74M
▼ -29.8% YoY
Net Debt
$353M
Cash & Equiv.
$318M
5Y CAGR: -0.9%
5Y CAGR: -8.5%
Continue Research
SourceComputed from the 10-Q filed 4 Aug 2026, covering the period ending 4 Jul 2026, as reported to the SEC. Data last refreshed 5 Aug 2026. How this is calculated.
Price from market data, live as of 3 Sept 2026. Fiscal year ends Jan. Sector medians are approximate S&P 500 benchmarks and update periodically.
Bluelinx Holdings (BXC) trades around a two-stage DCF intrinsic value of about $82.99 per share, so at $77.28 the stock looks around fair value (7.4% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Bluelinx Holdings scores 24/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $82.99 per share for BXC, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $62.24. At today's $77.28, that puts the stock about 7.4% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Bluelinx Holdings scores 24 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 2.4% operating margin and a 5.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. BXC currently trades around its estimated intrinsic value and scores 24/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.